EGFR and lung cancer: In case, without protein immunoprecipitation, the approach identified important glycosylation and phosphorylation on druggable protein, such as 10 of 12 N-glycosylation sites and driver autophosphorylation sites, such as Y1172 and Y1110 of EGFR protein, the druggable target in lung cancer (supplemental Fig. S4).